JPS6168476A - １，３‐ベンズチアゾールまたは１，３‐ベンズオキサゾール誘導体 - Google Patents

１，３‐ベンズチアゾールまたは１，３‐ベンズオキサゾール誘導体

Info

Publication number
JPS6168476A
JPS6168476A JP60201481A JP20148185A JPS6168476A JP S6168476 A JPS6168476 A JP S6168476A JP 60201481 A JP60201481 A JP 60201481A JP 20148185 A JP20148185 A JP 20148185A JP S6168476 A JPS6168476 A JP S6168476A
Authority
JP
Japan
Prior art keywords
acid
mixture
hydroxy
ethyl
mol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60201481A
Other languages
English (en)
Japanese (ja)
Inventor
オーラム・デイビツド・ストリンガー
ジヨセフ・ウエインストツク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of JPS6168476A publication Critical patent/JPS6168476A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP60201481A 1984-09-12 1985-09-10 １，３‐ベンズチアゾールまたは１，３‐ベンズオキサゾール誘導体 Pending JPS6168476A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US649466 1984-09-12
US06/649,466 US4554284A (en) 1984-09-12 1984-09-12 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones

Publications (1)

Publication Number Publication Date
JPS6168476A true JPS6168476A (ja) 1986-04-08

Family

ID=24604912

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60201481A Pending JPS6168476A (ja) 1984-09-12 1985-09-10 １，３‐ベンズチアゾールまたは１，３‐ベンズオキサゾール誘導体

Country Status (10)

Country Link
US (1) US4554284A (US20100056889A1-20100304-C00004.png)
EP (1) EP0174811A3 (US20100056889A1-20100304-C00004.png)
JP (1) JPS6168476A (US20100056889A1-20100304-C00004.png)
AU (1) AU581020B2 (US20100056889A1-20100304-C00004.png)
CA (1) CA1248115A (US20100056889A1-20100304-C00004.png)
DK (1) DK413585A (US20100056889A1-20100304-C00004.png)
ES (1) ES8700663A1 (US20100056889A1-20100304-C00004.png)
GR (1) GR852175B (US20100056889A1-20100304-C00004.png)
PT (1) PT81110B (US20100056889A1-20100304-C00004.png)
ZA (1) ZA856944B (US20100056889A1-20100304-C00004.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62277347A (ja) * 1986-02-25 1987-12-02 Microbial Chem Res Found 新規生理活性物質ア−ブスタチン類縁化合物

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1183453B (it) * 1985-03-01 1987-10-22 Minnesota Mining & Mfg Copulanti 2-equivalenti formatori di colorante cian 5-idrossi-6-acilammino-benzossazol-2-one, elementi fotografici agli alogenuri d'argento e procedimentiche li impiegano
US4720297A (en) * 1985-09-27 1988-01-19 Sumitomo Chemical Company, Limited Benzothiazolones, and their production and use as herbicides
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
FR2667068B1 (fr) * 1990-09-26 1994-09-09 Adir Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5268381A (en) * 1990-09-26 1993-12-07 Adir Et Compagnie Aminoalkyl-benzothiazolinone and -benzoxazolinone compounds having a high 5-HT1A affinity
US5234924A (en) * 1990-09-26 1993-08-10 Adir Et Compagnie Benzothiazine and benzothiazole compounds useful as analgesics
IE914003A1 (en) * 1990-11-20 1992-05-20 Astra Pharma Prod Biologically Active Amines
GB9210632D0 (en) * 1992-05-19 1992-07-01 Fisons Plc Compounds
GB9211172D0 (en) * 1992-05-27 1992-07-08 Fisons Plc Compounds
FR2674524B1 (fr) * 1991-03-25 1993-05-21 Adir Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2717810B1 (fr) * 1994-03-22 1996-04-26 Adir Nouvelles aminoalkyl benzoxazolinones et benzothiazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
TW356468B (en) * 1995-09-15 1999-04-21 Astra Pharma Prod Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same
GB9526511D0 (en) * 1995-12-23 1996-02-28 Astra Pharma Prod Pharmaceutically active compounds
US6749598B1 (en) 1999-01-11 2004-06-15 Flowmedica, Inc. Apparatus and methods for treating congestive heart disease
US7329236B2 (en) 1999-01-11 2008-02-12 Flowmedica, Inc. Intra-aortic renal drug delivery catheter
US7122019B1 (en) 2000-11-28 2006-10-17 Flowmedica Inc. Intra-aortic renal drug delivery catheter
US7481803B2 (en) 2000-11-28 2009-01-27 Flowmedica, Inc. Intra-aortic renal drug delivery catheter
US7780628B1 (en) 1999-01-11 2010-08-24 Angiodynamics, Inc. Apparatus and methods for treating congestive heart disease
US7063679B2 (en) 2002-09-20 2006-06-20 Flowmedica, Inc. Intra-aortic renal delivery catheter
JP2006513809A (ja) 2002-09-20 2006-04-27 フローメディカ，インコーポレイテッド 送達シースを通して大動脈内カテーテルを挿入するための装置および方法
AU2003294226A1 (en) 2002-09-20 2004-04-23 Flowmedica, Inc. Method and apparatus for intra aortic substance delivery to a branch vessel
US7993325B2 (en) 2002-09-20 2011-08-09 Angio Dynamics, Inc. Renal infusion systems and methods
WO2004032791A2 (en) 2002-09-20 2004-04-22 Flowmedica, Inc. Method and apparatus for selective material delivery via an intra-renal catheter
JP2006526464A (ja) 2003-06-05 2006-11-24 フローメディカ，インコーポレイテッド 分枝した身体管腔において両側介入または診断を行うためのシステムおよび方法
WO2005091910A2 (en) 2004-03-04 2005-10-06 Flowmedica, Inc. Sheath for use in peripheral interventions
JP2007537298A (ja) 2004-05-14 2007-12-20 フロウメディカ， インコーポレイテッド うっ血性心不全の処置およびｂｎｐ療法のための両側性局所腎臓送達
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
US7771401B2 (en) 2006-06-08 2010-08-10 Angiodynamics, Inc. Selective renal cannulation and infusion systems and methods
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
RU2455295C2 (ru) * 2006-12-20 2012-07-10 АстраЗенека AБ 4-ГИДРОКСИ-2-ОКСО-2,3-ДИГИДРО-1,3-БЕНЗОТИАЗОЛ-7-ИЛЬНЫЕ СОЕДИНЕНИЯ ДЛЯ МОДУЛЯЦИИ β2-АДРЕНОРЕЦЕПТОРНОЙ АКТИВНОСТИ
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
CN102124003A (zh) 2008-06-18 2011-07-13 阿斯利康(瑞典)有限公司 作为治疗呼吸系统疾病的β2肾上腺素受体拮抗剂的苯并噁嗪酮衍生物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2927352A1 (de) * 1979-07-06 1981-02-05 Thomae Gmbh Dr K In 6-stellung substituierte benzothiazol-2(3h)-one enthaltende arzneimittel
US4474965A (en) * 1980-01-25 1984-10-02 Monsanto Company 3-Substituted aminoalkyl-2-benzothiazolinones
US4314944A (en) * 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones
FR2491471A1 (fr) * 1980-10-03 1982-04-09 Cerm Cent Europ Rech Mauvernay Benzoxazolinones substituees, leur preparation et leur application en therapeutique
DE3134590A1 (de) * 1981-09-01 1983-03-10 Boehringer Ingelheim KG, 6507 Ingelheim Neue benzo-heterocyclen
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
FR2536749A1 (fr) * 1982-11-25 1984-06-01 Cerm Cent Europ Rech Mauvernay (amino-2 ethyl)-6 benzoxazolinones substituees, leur preparation et leurs applications en therapeutique
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62277347A (ja) * 1986-02-25 1987-12-02 Microbial Chem Res Found 新規生理活性物質ア−ブスタチン類縁化合物

Also Published As

Publication number Publication date
PT81110A (en) 1985-10-01
ZA856944B (en) 1986-06-25
AU4714385A (en) 1986-03-20
ES546886A0 (es) 1986-10-16
PT81110B (en) 1987-07-06
CA1248115A (en) 1989-01-03
GR852175B (US20100056889A1-20100304-C00004.png) 1986-01-10
DK413585D0 (da) 1985-09-11
US4554284A (en) 1985-11-19
DK413585A (da) 1986-03-13
EP0174811A3 (en) 1987-09-02
ES8700663A1 (es) 1986-10-16
EP0174811A2 (en) 1986-03-19
AU581020B2 (en) 1989-02-09

Similar Documents

Publication Publication Date Title
JPS6168476A (ja) １，３‐ベンズチアゾールまたは１，３‐ベンズオキサゾール誘導体
US5464872A (en) Arylalkyl (thio) amides
CS201040B2 (en) Method of producing etherified hydroxy-benzo-diheterocyclic compounds
NZ206344A (en) 4-omega-inoalkylindol-2(3h)-ones and pharmaceutical compositions
EP0243018B1 (en) Thiolactam-n-acetic acid derivatives, their production and use
Koo et al. Derivatives of 1, 4-benzodioxan. I. 1, 4-Benzodioxan-2-carboxamides
MX2009000786A (es) Derivados novedosos de cromeno- y tiocromeno-carboxamida, metodos para su preparacion y aplicaciones terapeuticas de los mismos.
CA2018307A1 (en) Halogen substituted diphenylsulfides
EP0012866B1 (en) New 3h-naphtho(1,2-d)imidazoles, processes for preparing them, compounds for use as antiinflammatory and antimicrobial agents and compositions for that use containing them
JPH06502635A (ja) 生物学的に活性なアミン
CA1255685A (en) Process for preparing 7-¬2-(dialkylamino)ethyl|-4- hydroxy-1,3-benzimidazol-2-ones
US4435417A (en) Antiinflammatory 3H-naphtho[1,2-d]imidazoles
EP0841330A1 (fr) Nouveaux dérivés aminométhyl hétérocycliques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
US4665083A (en) Iminothiazolidine derivatives
US3647802A (en) 2-amino-4-aryl-3 4-dihydroquinolines
JPH0687843A (ja) 新規複素環式化合物、それらの製造方法、およびそれらを含有する医薬組成物
US3420823A (en) Dibenzothiazines
CA1051436A (en) 4-amino-amphetamine derivatives
CA1152993A (en) 3h-naphtho [1,2-d]imidazoles, the process for preparing them, their use as antiinflammatory agents and compositions containing them
JPS611659A (ja) ４‐［２‐（ジアルキルアミノ）エチル］イサチン
GB2126230A (en) Substituted 1-pyridyloxy-3- indolylakylamino-2-propanols, preparation, and use thereof
JPS606658A (ja) 三置換オキサゾリジノン化合物
IE873441L (en) Indolecarboxamide derivatives.
JPS6040420B2 (ja) ３−アミノ−２−（５−フルオル−及び５−メトキシ−１ｈ−インド−ル−３−イル）プロパン酸誘導体類、その製法及び利用
US4663482A (en) Intermediates for preparing 7-(2-aminoethyl)-1,3-benzthia- or oxa- zol-2(3H)-ones